메뉴 건너뛰기




Volumn 10, Issue 8, 2010, Pages 768-778

Updating the chemistry and biology of cannabinoid CB2 receptor- specific inverse agonists

Author keywords

Cannabidiol; Cannabinoid CB2 receptor; Constitutive activity; Inflammation; Inverse agonist; Migration

Indexed keywords

3 (2 IODO 5 NITROBENZOYL) 1 (1 METHYL 2 PIPERIDINYLMETHYL)INDOLE; 5 (4 CHLORO 3 METHYLPHENYL) 1 (4 METHYLBENZYL) N (1,3,3 TRIMETHYLBICYCLO[2.2.1]HEPTAN 2 YL) 3 PYRAZOLECARBOXAMIDE; 6 IODO 3 (4 METHOXYBENZOYL) 2 METHYL 1 (2 MORPHOLINOETHYL)INDOLE; CANNABIDIOL; CANNABINOID 2 RECEPTOR; CHEMOKINE RECEPTOR;

EID: 78049285545     PISSN: 15680266     EISSN: None     Source Type: Journal    
DOI: 10.2174/156802610791164193     Document Type: Article
Times cited : (14)

References (102)
  • 1
    • 0027515373 scopus 로고
    • Molecular characterization of a peripheral receptor for cannabinoids
    • Munro, S.; Thomas, K. L.; Abu-Shaar, M. Molecular characterization of a peripheral receptor for cannabinoids. Nature, 1993, 365, 61-65.
    • (1993) Nature , vol.365 , pp. 61-65
    • Munro, S.1    Thomas, K.L.2    Abu-Shaar, M.3
  • 3
    • 20044386244 scopus 로고    scopus 로고
    • Distribution of cannabinoid receptor 1 (CB1) and 2 (CB2) on sensory nerve fibers and adnexal structures in human skin
    • Ständer, S.; Schmelz, M.; Metze, D.; Luger T.; Rukwied, R. Distribution of cannabinoid receptor 1 (CB1) and 2 (CB2) on sensory nerve fibers and adnexal structures in human skin. J. Dermatol. Sci., 2005, 38, 177-188.
    • (2005) J. Dermatol. Sci. , vol.38 , pp. 177-188
    • Ständer, S.1    Schmelz, M.2    Metze, D.3    Luger, T.4    Rukwied, R.5
  • 7
    • 68749110973 scopus 로고    scopus 로고
    • Functional CB2 type cannabinoid receptors at CNS synapses
    • Morgan, N. H.; Stanford, I. M.; Woodhall, G. L. Functional CB2 type cannabinoid receptors at CNS synapses. Neuropharmacology, 2009, 57, 356-368
    • (2009) Neuropharmacology , vol.57 , pp. 356-368
    • Morgan, N.H.1    Stanford, I.M.2    Woodhall, G.L.3
  • 8
    • 33846047809 scopus 로고    scopus 로고
    • Cerebral hypoxia-ischemia and middle cerebral artery occlusion induce expression of the cannabinoid CB2 receptor in the brain
    • Ashton, J. C.; Rahman, R. M.; Nair, S. M.; Sutherland, B.A.; Glass, M.; Appleton, I. Cerebral hypoxia-ischemia and middle cerebral artery occlusion induce expression of the cannabinoid CB2 receptor in the brain, Neurosci. Lett., 2007, 412, 114-117
    • (2007) Neurosci. Lett. , vol.412 , pp. 114-117
    • Ashton, J.C.1    Rahman, R.M.2    Nair, S.M.3    Sutherland, B.A.4    Glass, M.5    Appleton, I.6
  • 10
    • 14944367009 scopus 로고    scopus 로고
    • A glial endogenous cannabinoid system is upregulated in the brains of macaques with simian immunodeficiency virus-induced encephalitis
    • Benito, C.; Kim, W. K.; Chavarria, I.; Hillard, C. J.; Mackie, K.; Tolon, R. M.; Williams K.; Romero, J. A glial endogenous cannabinoid system is upregulated in the brains of macaques with simian immunodeficiency virus-induced encephalitis, J. Neurosci., 2005, 25, 2530-2536.
    • (2005) J. Neurosci. , vol.25 , pp. 2530-2536
    • Benito, C.1    Kim, W.K.2    Chavarria, I.3    Hillard, C.J.4    MacKie, K.5    Tolon, R.M.6    Williams, K.7    Romero, J.8
  • 11
    • 37849049077 scopus 로고    scopus 로고
    • Glial expression of cannabinoid CB(2) receptors and fatty acid amide hydrolase are beta amyloid-linked events in Down's syndrome
    • Núñez, E.; Benito, C.; Tolón, R. M.; Hillard, C. J.; Griffin, W. S.; Romero, J. Glial expression of cannabinoid CB(2) receptors and fatty acid amide hydrolase are beta amyloid-linked events in Down's syndrome, Neuroscience, 2008, 151, 104-110.
    • (2008) Neuroscience , vol.151 , pp. 104-110
    • Núñez, E.1    Benito, C.2    Tolón, R.M.3    Hillard, C.J.4    Griffin, W.S.5    Romero, J.6
  • 12
    • 0348010292 scopus 로고    scopus 로고
    • Cannabinoid CB2 receptors and fatty acid amide hydrolase are selectively overexpressed in neuritic plaqueassociated glia in Alzheimer's disease brains
    • Benito, C.; Nuñez, E.; Tolón, R. M.; Carrier, E. J.; Rabano, A.; Hillard, C. J.; Romero, J. Cannabinoid CB2 receptors and fatty acid amide hydrolase are selectively overexpressed in neuritic plaqueassociated glia in Alzheimer's disease brains, J. Neurosci., 2003, 23, 11136-11141.
    • (2003) J. Neurosci. , vol.23 , pp. 11136-11141
    • Benito, C.1    Nuñez, E.2    Tolón, R.M.3    Carrier, E.J.4    Rabano, A.5    Hillard, C.J.6    Romero, J.7
  • 13
    • 33847420442 scopus 로고    scopus 로고
    • Cannabinoid CB1 and CB2 receptors and fatty acid amide hydrolase are specific markers of plaque cell subtypes in human multiple sclerosis
    • Benito, C.; Romero, J. P.; Tolón, R. M.; Clemente, D.; Docagne, F.; Hillard, C. J.; Guaza, Romero, J. Cannabinoid CB1 and CB2 receptors and fatty acid amide hydrolase are specific markers of plaque cell subtypes in human multiple sclerosis, J. Neurosci., 2007, 27, 2396-2402.
    • (2007) J. Neurosci. , vol.27 , pp. 2396-2402
    • Benito, C.1    Romero, J.P.2    Tolón, R.M.3    Clemente, D.4    Docagne, F.5    Hillard, C.J.6    Guaza7    Romero, J.8
  • 14
    • 33645224970 scopus 로고    scopus 로고
    • COX-2, CB2 and P2X7- immunoreactivities are increased in activated microglial cells/macrophages of multiple sclerosis and amyotrophic lateral sclerosis spinal cord
    • Yiangou, Y.; Facer, P.; Durrenberger, P.; Chessell, I. P.; Naylor, A.; Bountra, C.; Banati, R. R.; Anand, P. COX-2, CB2 and P2X7- immunoreactivities are increased in activated microglial cells/macrophages of multiple sclerosis and amyotrophic lateral sclerosis spinal cord. BMC Neurol., 2006, 6, 12.
    • (2006) BMC Neurol , vol.6 , pp. 12
    • Yiangou, Y.1    Facer, P.2    Durrenberger, P.3    Chessell, I.P.4    Naylor, A.5    Bountra, C.6    Banati, R.R.7    Anand, P.8
  • 17
    • 58249109364 scopus 로고    scopus 로고
    • The GPR55 ligand L-alphalysophosphatidylinositol promotes RhoA-dependent Ca2+ signaling and NFAT activation
    • Henstridge, C. M.; Balenga, N. A.; Ford, L. A.; Ross, R. A.; Waldhoer, M.; Irving, A. J. The GPR55 ligand L-alphalysophosphatidylinositol promotes RhoA-dependent Ca2+ signaling and NFAT activation. FASEB J., 2009, 23, 183-193.
    • (2009) FASEB J , vol.23 , pp. 183-193
    • Henstridge, C.M.1    Balenga, N.A.2    Ford, L.A.3    Ross, R.A.4    Waldhoer, M.5    Irving, A.J.6
  • 18
    • 58149138962 scopus 로고    scopus 로고
    • 2-Arachidonoyl-sn-glycero-3-phosphoinositol: A Possible Natural Ligand for GPR55
    • Oka, S.; Toshida, T.; Maruyama, K.; Nakajima, K.; Yamashita, A.; Sugiura, T. 2-Arachidonoyl-sn-glycero-3-phosphoinositol: A Possible Natural Ligand for GPR55. J. Biochem., 2009, 145, 13-20.
    • (2009) J. Biochem. , vol.145 , pp. 13-20
    • Oka, S.1    Toshida, T.2    Maruyama, K.3    Nakajima, K.4    Yamashita, A.5    Sugiura, T.6
  • 19
    • 0032586885 scopus 로고    scopus 로고
    • Gi protein modulation induced by a selective inverse agonist for the peripheral cannabinoid receptor CB2: Implication for intracellular signalization cross-regulation
    • Bouaboula, M.; Desnoyer, N.; Carayon, P.; Combes, T.; Casellas, P. Gi protein modulation induced by a selective inverse agonist for the peripheral cannabinoid receptor CB2: implication for intracellular signalization cross-regulation. Mol. Pharmacol., 1999, 55, 473-480.
    • (1999) Mol. Pharmacol. , vol.55 , pp. 473-480
    • Bouaboula, M.1    Desnoyer, N.2    Carayon, P.3    Combes, T.4    Casellas, P.5
  • 20
    • 33947259630 scopus 로고    scopus 로고
    • Inverse agonism: From curiosity to accepted dogma, but is it clinically relevant
    • Parra, S.; Bond, R. A. Inverse agonism: from curiosity to accepted dogma, but is it clinically relevant? Curr. Opin. Pharmacol., 2007, 7, 146-150.
    • (2007) Curr. Opin. Pharmacol. , vol.7 , pp. 146-150
    • Parra, S.1    Bond, R.A.2
  • 21
    • 1942487845 scopus 로고    scopus 로고
    • Recent advances in drug action and therapeutics: Relevance of novel concepts in G-protein-coupled receptor and signal transduction pharmacology
    • Brink, C. B.; Harvey, B. H.; Bodenstein, J.; Venter, D. P.; Oliver, D. W. Recent advances in drug action and therapeutics: Relevance of novel concepts in G-protein-coupled receptor and signal transduction pharmacology. Br. J. Clin. Pharmacol., 2004, 57, 373-387.
    • (2004) Br. J. Clin. Pharmacol. , vol.57 , pp. 373-387
    • Brink, C.B.1    Harvey, B.H.2    Bodenstein, J.3    Venter, D.P.4    Oliver, D.W.5
  • 22
    • 34247898951 scopus 로고    scopus 로고
    • The endocannabinoid system and rimonabant: A new drug with a novel mechanism of action involving cannabinoid CB1 receptor antagonism--or inverse agonism--as potential obesity treatment and other therapeutic use
    • Xie, S.; Furjanic, M. A.; Ferrara, J. J.; McAndrew, N. R.; Ardino, E. L.; Ngondara, A.; Bernstein, Y.; Thomas, K. J.; Kim, E.; Walker, J. M.; Nagar, S.; Ward, S. J.; Raffa, R. B. The endocannabinoid system and rimonabant: a new drug with a novel mechanism of action involving cannabinoid CB1 receptor antagonism--or inverse agonism--as potential obesity treatment and other therapeutic use. J. Clin. Pharm. Ther., 2007, 32, 209-231.
    • (2007) J. Clin. Pharm. Ther. , vol.32 , pp. 209-231
    • Xie, S.1    Furjanic, M.A.2    Ferrara, J.J.3    McAndrew, N.R.4    Ardino, E.L.5    Ngondara, A.6    Bernstein, Y.7    Thomas, K.J.8    Kim, E.9    Walker, J.M.10    Nagar, S.11    Ward, S.J.12    Raffa, R.B.13
  • 23
    • 57049102251 scopus 로고    scopus 로고
    • End of the line for cannabinoid receptor 1 as an antiobesity target? Nat
    • Jones, D. End of the line for cannabinoid receptor 1 as an antiobesity target? Nat. Rev. Drug Discov., 2008, 7, 961-962.
    • (2008) Rev. Drug Discov. , vol.7 , pp. 961-962
    • Jones, D.1
  • 25
    • 65649122618 scopus 로고    scopus 로고
    • Cannabinoid receptor antagonists: Pharmacological opportunities, clinical experience, and translational prognosis
    • Janero, D. R.; Makriyannis, A. Cannabinoid receptor antagonists: pharmacological opportunities, clinical experience, and translational prognosis. Expert Opin. Emerg. Drugs, 2009, 14, 43-65.
    • (2009) Expert Opin. Emerg. Drugs , vol.14 , pp. 43-65
    • Janero, D.R.1    Makriyannis, A.2
  • 26
    • 40349101686 scopus 로고    scopus 로고
    • Recent advances in the development of selective ligands for the cannabinoid CB(2) receptor
    • Marriott, K. S.; Huffman, J. W. Recent advances in the development of selective ligands for the cannabinoid CB(2) receptor. Curr. Top. Med. Chem., 2008, 8, 187-204.
    • (2008) Curr. Top. Med. Chem. , vol.8 , pp. 187-204
    • Marriott, K.S.1    Huffman, J.W.2
  • 27
    • 62749123023 scopus 로고    scopus 로고
    • Cannabinoid type 2 receptor as a target for chronic pain
    • Beltramo, M. Cannabinoid type 2 receptor as a target for chronic pain. Mini Rev. Med. Chem., 2009, 9, 11-25.
    • (2009) Mini Rev. Med. Chem. , vol.9 , pp. 11-25
    • Beltramo, M.1
  • 28
    • 63049105150 scopus 로고    scopus 로고
    • Emerging role of the cannabinoid receptor CB2 in immune regulation: Therapeutic prospects for neuroinflammation
    • Cabral, G. A.; Griffin-Thomas, L. Emerging role of the cannabinoid receptor CB2 in immune regulation: therapeutic prospects for neuroinflammation. Expert Rev. Mol. Med., 2009, 11 (e3), 1-25
    • (2009) Expert Rev. Mol. Med. , vol.11 , Issue.e3 , pp. 1-25
    • Cabral, G.A.1    Griffin-Thomas, L.2
  • 30
    • 40349101686 scopus 로고    scopus 로고
    • Recent advances in the development of selective ligands for the cannabinoid CB(2) receptor
    • Marriott, K. S.; Huffman, J. W. Recent advances in the development of selective ligands for the cannabinoid CB(2) receptor. Curr. Top. Med. Chem., 2008, 8, 187-204.
    • (2008) Curr. Top. Med. Chem. , vol.8 , pp. 187-204
    • Marriott, K.S.1    Huffman, J.W.2
  • 31
    • 21044458324 scopus 로고    scopus 로고
    • Current knowledge on the antagonists and inverse agonists of cannabinoid receptors
    • Muccioli, G. G.; Lambert, D. M. Current knowledge on the antagonists and inverse agonists of cannabinoid receptors. Curr. Med. Chem., 2005, 12, 1361-1394.
    • (2005) Curr. Med. Chem. , vol.12 , pp. 1361-1394
    • Muccioli, G.G.1    Lambert, D.M.2
  • 32
    • 18444386531 scopus 로고    scopus 로고
    • Targeting the cannabinoid CB2 receptor: Mutations, modeling and development of CB2 selective ligands
    • Raitio, K. H.; Salo, O. M.; Nevalainen, T.; Poso, A.; Järvinen, T. Targeting the cannabinoid CB2 receptor: mutations, modeling and development of CB2 selective ligands. Curr. Med. Chem., 2005, 12, 1217-1237.
    • (2005) Curr. Med. Chem. , vol.12 , pp. 1217-1237
    • Raitio, K.H.1    Salo, O.M.2    Nevalainen, T.3    Poso, A.4    Järvinen, T.5
  • 35
    • 0035142746 scopus 로고    scopus 로고
    • In Vitro and in Vivo pharmacological characterization of JTE-907, a novel selective ligand for cannabinoid CB2 receptor
    • Iwamura, H.; Suzuki, H.; Ueda, Y.; Kaya, T.; Inaba, T. In Vitro and in Vivo pharmacological characterization of JTE-907, a novel selective ligand for cannabinoid CB2 receptor. J. Pharma. Exp. Ther., 2001, 296, 420-425.
    • (2001) J. Pharma. Exp. Ther. , vol.296 , pp. 420-425
    • Iwamura, H.1    Suzuki, H.2    Ueda, Y.3    Kaya, T.4    Inaba, T.5
  • 37
  • 38
    • 50249127710 scopus 로고    scopus 로고
    • Design and synthesis of a novel series of N-alkyl isatin acylhydrazone derivatives that act as selective cannabinoid receptor 2 agonists for the treatment of neuropathic pain
    • Diaz, P.; Xu, J.; Astruc-Diaz, F.; Pan, H. M.; Brown, D. L.; Naguib, M. Design and synthesis of a novel series of N-alkyl isatin acylhydrazone derivatives that act as selective cannabinoid receptor 2 agonists for the treatment of neuropathic pain. J. Med. Chem., 2008, 51, 4932-4947.
    • (2008) J. Med. Chem. , vol.51 , pp. 4932-4947
    • Diaz, P.1    Xu, J.2    Astruc-Diaz, F.3    Pan, H.M.4    Brown, D.L.5    Naguib, M.6
  • 39
    • 60549101109 scopus 로고    scopus 로고
    • 6-Methoxy-N-alkyl isatin acylhydrazone derivatives as a novel series of potent selective cannabinoid receptor 2 inverse agonists: Design, synthesis, and binding mode prediction
    • Diaz, P.; Phatak, S. S.; Xu, J.; Astruc-Diaz, F.; Cavasotto, C. N.; Naguib, M. 6-Methoxy-N-alkyl isatin acylhydrazone derivatives as a novel series of potent selective cannabinoid receptor 2 inverse agonists: design, synthesis, and binding mode prediction. J. Med. Chem., 2009, 52, 433-444.
    • (2009) J. Med. Chem. , vol.52 , pp. 433-444
    • Diaz, P.1    Phatak, S.S.2    Xu, J.3    Astruc-Diaz, F.4    Cavasotto, C.N.5    Naguib, M.6
  • 42
    • 40149095112 scopus 로고    scopus 로고
    • Ligand-specific changes in M3 muscarinic acetylcholine receptor structure detected by a disulfide scanning strategy
    • Li, J. H.; Hamdan, F. F.; Kim, S. K.; Jacobson, K. A.; Zhang, X.; Han, S. J.; Wess, J. Ligand-specific changes in M3 muscarinic acetylcholine receptor structure detected by a disulfide scanning strategy. Biochemistry, 2008, 47, 2776-2788.
    • (2008) Biochemistry , vol.47 , pp. 2776-2788
    • Li, J.H.1    Hamdan, F.F.2    Kim, S.K.3    Jacobson, K.A.4    Zhang, X.5    Han, S.J.6    Wess, J.7
  • 43
    • 34447530948 scopus 로고    scopus 로고
    • Identification of an efficacy switch region in the ghrelin receptor responsible for interchange between agonis m and inverse agonism
    • Holst, B.; Mokrosinski, J.; Lang, M.; Brandt, E.; Nygaard, R.; Frimurer, T. M.; Beck-Sickinger, A. G.; Schwartz, T. W. Identification of an efficacy switch region in the ghrelin receptor responsible for interchange between agonis m and inverse agonism. J. Biol. Chem., 2007, 282, 15799-15811.
    • (2007) J. Biol. Chem. , vol.282 , pp. 15799-15811
    • Holst, B.1    Mokrosinski, J.2    Lang, M.3    Brandt, E.4    Nygaard, R.5    Frimurer, T.M.6    Beck-Sickinger, A.G.7    Schwartz, T.W.8
  • 44
    • 58849154165 scopus 로고    scopus 로고
    • Residues accessible in the binding-site crevice of transmembrane helix 6 of the CB2 cannabinoid receptor
    • Nebane, N. M.; Hurst, D. P.; Carrasquer, C. A.; Qiao, Z.; Reggio, P. H.; Song, Z.-H. Residues accessible in the binding-site crevice of transmembrane helix 6 of the CB2 cannabinoid receptor. Biochemistry, 2008, 47, 13811-13821.
    • (2008) Biochemistry , vol.47 , pp. 13811-13821
    • Nebane, N.M.1    Hurst, D.P.2    Carrasquer, C.A.3    Qiao, Z.4    Reggio, P.H.5    Song, Z.-H.6
  • 45
    • 22744435568 scopus 로고    scopus 로고
    • Identification of WIN55212-3 as a competitive neutral antagonist of the human cannabinoid CB2 receptor
    • Savinainen, J. R.; Kokkola, T.; Salo, O. M.; Poso, A.; Järvinen, T.; Laitinen, J. T. Identification of WIN55212-3 as a competitive neutral antagonist of the human cannabinoid CB2 receptor. Br. J. Pharmacol., 2005, 145, 636-645.
    • (2005) Br. J. Pharmacol. , vol.145 , pp. 636-645
    • Savinainen, J.R.1    Kokkola, T.2    Salo, O.M.3    Poso, A.4    Järvinen, T.5    Laitinen, J.T.6
  • 47
    • 56049101882 scopus 로고    scopus 로고
    • Ligand-binding architecture of human CB2 cannabinoid receptor: Evidence for receptor subtype-specific binding motif and modeling GPCR activation
    • Pei Y.; Mercier, R. W.; Anday, J. K.; Thakur, G. A.; Zvonok, A. M.; Hurst, D.; Reggio, P. H.; Janero, D. R.; Makriyannis, A. Ligand-binding architecture of human CB2 cannabinoid receptor: evidence for receptor subtype-specific binding motif and modeling GPCR activation. Chem. Biol., 2008, 15, 1207-1219.
    • (2008) Chem. Biol. , vol.15 , pp. 1207-1219
    • Pei, Y.1    Mercier, R.W.2    Anday, J.K.3    Thakur, G.A.4    Zvonok, A.M.5    Hurst, D.6    Reggio, P.H.7    Janero, D.R.8    Makriyannis, A.9
  • 52
    • 0030840923 scopus 로고    scopus 로고
    • Protean agonists. Keys to receptor active states?
    • Kenakin, T. Protean agonists. Keys to receptor active states? Ann. N. Y. Acad. Sci., 1997, 812, 116-125.
    • (1997) Ann. N. Y. Acad. Sci. , vol.812 , pp. 116-125
    • Kenakin, T.1
  • 54
    • 0032410647 scopus 로고    scopus 로고
    • Protean effects of a natural peptide agonist of the G protein-coupled secretin receptor demonstrated by receptor mutagenesis
    • Ganguli, S. C.; Park, C. G.; Holtmann, M. H.; Hadac, E. M.; Kenakin, T. P.; Miller, L. J. Protean effects of a natural peptide agonist of the G protein-coupled secretin receptor demonstrated by receptor mutagenesis. J. Pharmacol. Exp. Ther., 1998, 286, 593-598.
    • (1998) J. Pharmacol. Exp. Ther. , vol.286 , pp. 593-598
    • Ganguli, S.C.1    Park, C.G.2    Holtmann, M.H.3    Hadac, E.M.4    Kenakin, T.P.5    Miller, L.J.6
  • 56
    • 0038137537 scopus 로고    scopus 로고
    • Dissimilar pharmacological responses by a new series of imidazoline derivatives at precoupled and ligand-activated alpha 2A-adrenoceptor states: Evidence for effector pathway-dependent differential antagonism
    • Pauwels, P. J.; Rauly, I.; Wurch, T. Dissimilar pharmacological responses by a new series of imidazoline derivatives at precoupled and ligand-activated alpha 2A-adrenoceptor states: evidence for effector pathway-dependent differential antagonism. J. Pharmacol. Exp. Ther., 2003, 305, 1015-1023.
    • (2003) J. Pharmacol. Exp. Ther. , vol.305 , pp. 1015-1023
    • Pauwels, P.J.1    Rauly, I.2    Wurch, T.3
  • 58
    • 61349200341 scopus 로고    scopus 로고
    • Design and synthesis of novel tri-aryl CB2 selective cannabinoid ligands
    • Bhattacharjee, H.; Gurley, S. N., Moore II, B. M. Design and synthesis of novel tri-aryl CB2 selective cannabinoid ligands. Bioorg. Med. Chem. Lett., 2009, 19, 1691-1693.
    • (2009) Bioorg. Med. Chem. Lett. , vol.19 , pp. 1691-1693
    • Bhattacharjee, H.1    Gurley, S.N.2    Moore II, B.M.3
  • 60
    • 55749113512 scopus 로고    scopus 로고
    • Reciprocal influences of CB1 cannabinoid receptor agonists on ERK and JNK signalling in N1E-115 cells
    • Bosier, B.; Lambert, D. M.; Hermans, E. Reciprocal influences of CB1 cannabinoid receptor agonists on ERK and JNK signalling in N1E-115 cells. FEBS Lett., 2008, 582, 3861-3867.
    • (2008) FEBS Lett , vol.582 , pp. 3861-3867
    • Bosier, B.1    Lambert, D.M.2    Hermans, E.3
  • 61
    • 57249103358 scopus 로고    scopus 로고
    • Concomitant activation of adenylyl cyclase suppresses the opposite influences of CB(1) cannabinoid receptor agonists on tyrosine hydroxylase expression
    • Bosier, B.; Hermans, E.; Lambert, D. M. Concomitant activation of adenylyl cyclase suppresses the opposite influences of CB(1) cannabinoid receptor agonists on tyrosine hydroxylase expression. Biochem. Pharmacol., 2009, 77, 216-227.
    • (2009) Biochem. Pharmacol. , vol.77 , pp. 216-227
    • Bosier, B.1    Hermans, E.2    Lambert, D.M.3
  • 62
    • 0032756226 scopus 로고    scopus 로고
    • Agonist selective regulation of G proteins by cannabinoid CB(1) and CB(2) receptors
    • Glass, M.; Northup, J. K. Agonist selective regulation of G proteins by cannabinoid CB(1) and CB(2) receptors. Mol. Pharmacol., 1999, 56, 1362-1369.
    • (1999) Mol. Pharmacol. , vol.56 , pp. 1362-1369
    • Glass, M.1    Northup, J.K.2
  • 63
    • 54249137719 scopus 로고    scopus 로고
    • Differential coupling of the human cannabinoid receptors hCB1R and hCB2R to the G-protein G(alpha)i2beta1gamma2
    • Nickl, K.; Gardner, E. E.; Geiger, S.; Heilmann, J.; Seifert, R. Differential coupling of the human cannabinoid receptors hCB1R and hCB2R to the G-protein G(alpha)i2beta1gamma2. Neurosci. Lett., 2008, 447, 68-72.
    • (2008) Neurosci. Lett. , vol.447 , pp. 68-72
    • Nickl, K.1    Gardner, E.E.2    Geiger, S.3    Heilmann, J.4    Seifert, R.5
  • 64
    • 0038540318 scopus 로고    scopus 로고
    • Biochemical and pharmacological control of the multiplicity of coupling at G-protein-coupled receptors
    • Hermans, E. Biochemical and pharmacological control of the multiplicity of coupling at G-protein-coupled receptors. Pharmacol. Ther., 2003, 99, 25-44.
    • (2003) Pharmacol. Ther. , vol.99 , pp. 25-44
    • Hermans, E.1
  • 65
    • 63849235865 scopus 로고    scopus 로고
    • Evaluating cellular impedance assays for detection of GPCR pleiotropic signaling and functional selectivity
    • Peters, M. F.; Scott, C. W. Evaluating cellular impedance assays for detection of GPCR pleiotropic signaling and functional selectivity. J. Biomol. Screen., 2009, 14, 246-255.
    • (2009) J. Biomol. Screen. , vol.14 , pp. 246-255
    • Peters, M.F.1    Scott, C.W.2
  • 66
    • 58249122333 scopus 로고    scopus 로고
    • Characterization of human cannabinoid CB2 receptor coupled to chimeric Galpha(qi5) and Galpha(qo5) proteins
    • Malysz, J.; Daza, A. V.; Kage, K.; Grayson, G. K.; Yao, B. B.; Meyer, M. D.; Gopalakrishnan, M. Characterization of human cannabinoid CB2 receptor coupled to chimeric Galpha(qi5) and Galpha(qo5) proteins. Eur. J. Pharmacol., 2009, 603, 12-21.
    • (2009) Eur. J. Pharmacol. , vol.603 , pp. 12-21
    • Malysz, J.1    Daza, A.V.2    Kage, K.3    Grayson, G.K.4    Yao, B.B.5    Meyer, M.D.6    Gopalakrishnan, M.7
  • 68
    • 42749095676 scopus 로고    scopus 로고
    • Translocation of arrestin induced by human A3 adenosine receptor ligands in an engineered cell line: Comparison with G protein-dependent pathways
    • Gao, Z.-G.; Jacobson, K. A. Translocation of arrestin induced by human A3 adenosine receptor ligands in an engineered cell line: Comparison with G protein-dependent pathways. Pharmacol. Res., 2008, 57, 303-311.
    • (2008) Pharmacol. Res. , vol.57 , pp. 303-311
    • Gao, Z.-G.1    Jacobson, K.A.2
  • 70
    • 33751533776 scopus 로고    scopus 로고
    • New roles for betaarrestins in cell signaling: Not just for seven-transmembrane receptors
    • Lefkowitz, R. J.; Rajagopal, K.; Whalen, E. J. New roles for betaarrestins in cell signaling: not just for seven-transmembrane receptors. Mol. Cell, 2006, 24, 643-652.
    • (2006) Mol. Cell , vol.24 , pp. 643-652
    • Lefkowitz, R.J.1    Rajagopal, K.2    Whalen, E.J.3
  • 71
    • 0141483377 scopus 로고    scopus 로고
    • A beta-arrestindependent scaffold is associated with prolonged MAPK activation in pseudopodia during protease-activated receptor-2-induced chemotaxis
    • Ge, L.; Ly, Y.; Hollenberg, M.; DeFea, K. A beta-arrestindependent scaffold is associated with prolonged MAPK activation in pseudopodia during protease-activated receptor-2-induced chemotaxis. J. Biol. Chem., 2003, 278, 34418-34426.
    • (2003) J. Biol. Chem. , vol.278 , pp. 34418-34426
    • Ge, L.1    Ly, Y.2    Hollenberg, M.3    Defea, K.4
  • 75
    • 58849083281 scopus 로고    scopus 로고
    • Characterizing cannabinoid CB2 receptor ligands using discoveRx pathHunterTM {beta}-arrestin assay
    • McGuinness, D.; Malikzay, A.; Visconti, R.; Lin, K.; Bayne, M.; Monsma, F.; Lunn, C. A. Characterizing cannabinoid CB2 receptor ligands using discoveRx pathHunterTM {beta}-arrestin assay. J. Biomol. Screen., 2009, 14, 49-58.
    • (2009) J. Biomol. Screen. , vol.14 , pp. 49-58
    • McGuinness, D.1    Malikzay, A.2    Visconti, R.3    Lin, K.4    Bayne, M.5    Monsma, F.6    Lunn, C.A.7
  • 77
    • 17844410926 scopus 로고    scopus 로고
    • Concurrent stimulation of cannabinoid CB1 and dopamine D2 receptors enhances heterodimer formation: A mechanism for receptor cross-talk?
    • Kearn, C. S.; Blake-Palmer, K.; Daniel, E.; Mackie, K.; Glass, M. Concurrent stimulation of cannabinoid CB1 and dopamine D2 receptors enhances heterodimer formation: a mechanism for receptor cross-talk? Mol. Pharmacol., 2005, 67, 1697-1704.
    • (2005) Mol. Pharmacol. , vol.67 , pp. 1697-1704
    • Kearn, C.S.1    Blake-Palmer, K.2    Daniel, E.3    MacKie, K.4    Glass, M.5
  • 78
    • 33846030175 scopus 로고    scopus 로고
    • Orexin-1 receptor-cannabinoid CB1 receptor heterodimerization results in both ligand-dependent and -independent coordinated alterations of receptor localization and function
    • Ellis, J.; Pediani, J. D.; Canals, M.; Milasta, S.; Milligan, G. Orexin-1 receptor-cannabinoid CB1 receptor heterodimerization results in both ligand-dependent and -independent coordinated alterations of receptor localization and function. J. Biol. Chem., 2006, 281, 38812-38824.
    • (2006) J. Biol. Chem. , vol.281 , pp. 38812-38824
    • Ellis, J.1    Pediani, J.D.2    Canals, M.3    Milasta, S.4    Milligan, G.5
  • 79
    • 43449130045 scopus 로고    scopus 로고
    • The cannabinoid delta-9-tetrahydrocannabinol mediates inhibition of macrophage chemotaxis to RANTES/CCL5: Linkage to the CB2 receptor
    • Raborn, E. S.; Marciano-Cabral, F.; Buckley, N. E.; Martin, B. R.; Cabral, G. A. The cannabinoid delta-9-tetrahydrocannabinol mediates inhibition of macrophage chemotaxis to RANTES/CCL5: linkage to the CB2 receptor. J. Neuroimmune Pharmacol., 2008, 3, 117-129
    • (2008) J. Neuroimmune Pharmacol. , vol.3 , pp. 117-129
    • Raborn, E.S.1    Marciano-Cabral, F.2    Buckley, N.E.3    Martin, B.R.4    Cabral, G.A.5
  • 80
    • 52049093883 scopus 로고    scopus 로고
    • Endocannabinoids as positive or negative factors in hematopoietic cell migration and differentiation
    • Patinkin, D.; Milman, G.; Breuer, A.; Fride, E.; Mechoulam, R. Endocannabinoids as positive or negative factors in hematopoietic cell migration and differentiation. Eur. J. Pharmacol., 2008, 595, 1-6.
    • (2008) Eur. J. Pharmacol. , vol.595 , pp. 1-6
    • Patinkin, D.1    Milman, G.2    Breuer, A.3    Fride, E.4    Mechoulam, R.5
  • 81
    • 35448940523 scopus 로고    scopus 로고
    • Induction of preferential chemotaxis of unstimulated B-lymphocytes by 2-arachidonoylglycerol in immunized mice
    • Tanikawa, T.; Kurohane, K.; Imai, Y. Induction of preferential chemotaxis of unstimulated B-lymphocytes by 2-arachidonoylglycerol in immunized mice. Microbiol. Immunol., 2007, 51, 1013-1019.
    • (2007) Microbiol. Immunol. , vol.51 , pp. 1013-1019
    • Tanikawa, T.1    Kurohane, K.2    Imai, Y.3
  • 82
    • 39849087246 scopus 로고    scopus 로고
    • Expression and function of cannabinoid receptors CB1 and CB2 and their cognate cannabinoid ligands in murine embryonic stem cells
    • doi: 10.1371/ journal.pone.0000641
    • Jiang, S.; Fu, Y.; Williams, J.; Wood, J.; Pandarinathan, L.; Avraham, S.; Makriyannis, A.; Avraham, S.; Avraham, H. K. Expression and function of cannabinoid receptors CB1 and CB2 and their cognate cannabinoid ligands in murine embryonic stem cells. PLoS ONE, 2007, 2, e641, doi: 10.1371/ journal.pone.0000641.
    • (2007) PLoS ONE , vol.2
    • Jiang, S.1    Fu, Y.2    Williams, J.3    Wood, J.4    Pandarinathan, L.5    Avraham, S.6    Makriyannis, A.7    Avraham, S.8    Avraham, H.K.9
  • 83
    • 33745065869 scopus 로고    scopus 로고
    • Chemotaxis of human peripheral blood eosinophils to 2-arachidonoylglycerol: Comparison with other eosinophil chemoattractants
    • Kishimoto, S.; Oka, S.; Gokoh, M.; Sugiura, T. Chemotaxis of human peripheral blood eosinophils to 2-arachidonoylglycerol: comparison with other eosinophil chemoattractants. Int. Arch. Allergy Immunol., 2006, 140, 3-7.
    • (2006) Int. Arch. Allergy Immunol. , vol.140 , pp. 3-7
    • Kishimoto, S.1    Oka, S.2    Gokoh, M.3    Sugiura, T.4
  • 84
    • 41549162387 scopus 로고    scopus 로고
    • CB2 cannabinoid receptor agonist JWH-015 modulates human monocyte migration through defined intracellular signaling pathways
    • Montecucco, F.; Burger, F.; Mach, F.; Steffens, S. CB2 cannabinoid receptor agonist JWH-015 modulates human monocyte migration through defined intracellular signaling pathways. Am. J. Physiol. Heart Circ. Physiol., 2008, 294, H1145-55.
    • (2008) Am. J. Physiol. Heart Circ. Physiol. , vol.294
    • Montecucco, F.1    Burger, F.2    Mach, F.3    Steffens, S.4
  • 85
    • 38549130466 scopus 로고    scopus 로고
    • Inhibition of human neutrophil chemotaxis by endogenous cannabinoids and phytocannabinoids: Evidence for a site distinct from CB1 and CB2
    • McHugh, D.; Tanner, C.; Mechoulam, R.; Pertwee, R. G.; Ross, R. A. Inhibition of human neutrophil chemotaxis by endogenous cannabinoids and phytocannabinoids: evidence for a site distinct from CB1 and CB2. Mol. Pharmacol., 2008, 73, 441-450.
    • (2008) Mol. Pharmacol. , vol.73 , pp. 441-450
    • McHugh, D.1    Tanner, C.2    Mechoulam, R.3    Pertwee, R.G.4    Ross, R.A.5
  • 87
    • 33846583671 scopus 로고    scopus 로고
    • Temporal variation in CB2R levels following T lymphocyte activation: Evidence that cannabinoids modulate CXCL12-induced chemotaxis
    • Coopman, K.; Smith, L. D.; Wright, K. L.; Ward, S. G. Temporal variation in CB2R levels following T lymphocyte activation: evidence that cannabinoids modulate CXCL12-induced chemotaxis. Int. Immunopharmacol., 2007, 7, 360-371.
    • (2007) Int. Immunopharmacol. , vol.7 , pp. 360-371
    • Coopman, K.1    Smith, L.D.2    Wright, K.L.3    Ward, S.G.4
  • 88
    • 34548446421 scopus 로고    scopus 로고
    • Anti-inflammatory property of the cannabinoid receptor-2-selective agonist JWH-133 in a rodent model of autoimmune uveoretinitis
    • Xu, H.; Cheng, C. L.; Chen, M.; Manivannan, A.; Cabay, L.; Pertwee, R. G.; Coutts, A.; Forrester, J. V. Anti-inflammatory property of the cannabinoid receptor-2-selective agonist JWH-133 in a rodent model of autoimmune uveoretinitis. J. Leukoc. Biol., 2007, 82, 532-541.
    • (2007) J. Leukoc. Biol. , vol.82 , pp. 532-541
    • Xu, H.1    Cheng, C.L.2    Chen, M.3    Manivannan, A.4    Cabay, L.5    Pertwee, R.G.6    Coutts, A.7    Forrester, J.V.8
  • 89
    • 34250717998 scopus 로고    scopus 로고
    • Cannabinoid CB(2) receptor activation decreases cerebral infarction in a mouse focal ischemia/reperfusion model
    • Zhang, M.; Martin, B. R.; Adler, M. W.; Razdan, R. K.; Jallo, J. I.; Tuma, R. F. Cannabinoid CB(2) receptor activation decreases cerebral infarction in a mouse focal ischemia/reperfusion model. J. Cereb. Blood Flow Metab., 2007, 27, 1387-1396.
    • (2007) J. Cereb. Blood Flow Metab. , vol.27 , pp. 1387-1396
    • Zhang, M.1    Martin, B.R.2    Adler, M.W.3    Razdan, R.K.4    Jallo, J.I.5    Tuma, R.F.6
  • 90
    • 33749261955 scopus 로고    scopus 로고
    • Targeting the CB2 receptor for immune modulation
    • Lunn, C. A.; Reich, E. P.; Bober, L. Targeting the CB2 receptor for immune modulation. Expert Opin. Ther. Targets, 2006, 10, 653-663.
    • (2006) Expert Opin. Ther. Targets , vol.10 , pp. 653-663
    • Lunn, C.A.1    Reich, E.P.2    Bober, L.3
  • 93
    • 54349124546 scopus 로고    scopus 로고
    • Regulation of bone mass, osteoclast function, and ovariectomy-induced bone loss by the type 2 cannabinoid receptor
    • Idris, A. I.; Sophocleous, A.; Landao-Bassonga, E.; van't Hof, R. J.; Ralston, S. H. Regulation of bone mass, osteoclast function, and ovariectomy-induced bone loss by the type 2 cannabinoid receptor. Endocrinology, 2008, 149, 5619-5626.
    • (2008) Endocrinology , vol.149 , pp. 5619-5626
    • Idris, A.I.1    Sophocleous, A.2    Landao-Bassonga, E.3    van't Hof, R.J.4    Ralston, S.H.5
  • 97
    • 38349132542 scopus 로고    scopus 로고
    • Cannabinoid receptors and the regulation of bone mass
    • Bab, I.; Zimmer, A. Cannabinoid receptors and the regulation of bone mass. Br. J. Pharmacol., 2008, 153, 182-188.
    • (2008) Br. J. Pharmacol. , vol.153 , pp. 182-188
    • Bab, I.1    Zimmer, A.2
  • 98
    • 33845811458 scopus 로고    scopus 로고
    • Involvement of cannabinoid CB2 receptors in the IgE-mediated triphasic cutaneous reaction in mice
    • Ueda, Y.; Miyagawa, N.; Wakitani, K. Involvement of cannabinoid CB2 receptors in the IgE-mediated triphasic cutaneous reaction in mice. Life Sci., 2007, 80, 414-419.
    • (2007) Life Sci , vol.80 , pp. 414-419
    • Ueda, Y.1    Miyagawa, N.2    Wakitani, K.3
  • 99
    • 33745997333 scopus 로고    scopus 로고
    • The cannabinoid CB2 receptor inverse agonist JTE-907 suppresses spontaneous itch-associated responses of NC mice, a model of atopic dermatitis
    • Maekawa, T.; Nojima, H.; Kuraishi, Y.; Aisaka, K. The cannabinoid CB2 receptor inverse agonist JTE-907 suppresses spontaneous itch-associated responses of NC mice, a model of atopic dermatitis. Eur. J. Pharmacol., 2006, 542, 179-183.
    • (2006) Eur. J. Pharmacol. , vol.542 , pp. 179-183
    • Maekawa, T.1    Nojima, H.2    Kuraishi, Y.3    Aisaka, K.4
  • 101
    • 33847653702 scopus 로고    scopus 로고
    • Cannabidiol displays unexpectedly high potency as an antagonist of CB1 and CB2 receptor agonists in vitro
    • Thomas, A.; Baillie, G. L.; Phillips, A. M.; Razdan, R. K.; Ross, R. A.; Pertwee, R. G. Cannabidiol displays unexpectedly high potency as an antagonist of CB1 and CB2 receptor agonists in vitro. Br. J. Pharmacol., 2007, 150, 613-623.
    • (2007) Br. J. Pharmacol. , vol.150 , pp. 613-623
    • Thomas, A.1    Baillie, G.L.2    Phillips, A.M.3    Razdan, R.K.4    Ross, R.A.5    Pertwee, R.G.6
  • 102
    • 34447642715 scopus 로고    scopus 로고
    • The evasive nature of drug efficacy: Implications for drug discovery
    • Galandrin, S.; Oligny-Longpré, G.; Bouvier, M. The evasive nature of drug efficacy: implications for drug discovery. Trends Pharmacol. Sci., 2007, 28, 423-430.
    • (2007) Trends Pharmacol. Sci. , vol.28 , pp. 423-430
    • Galandrin, S.1    Oligny-Longpré, G.2    Bouvier, M.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.